Gout: diagnosis and management-summary of NICE guidance

BMJ. 2022 Aug 30:378:o1754. doi: 10.1136/bmj.o1754.

Authors

Julie Neilson¹, Alexandra Bonnon², Alastair Dickson^{3

4}, Edward Roddy^{5

6}; Guideline Committee

Affiliations

¹ National Institute for Health and Care Excellence, Piccadilly Plaza, Manchester M1 4BT, UK Julie.neilson@nice.org.uk.
² National Institute for Health and Care Excellence, Piccadilly Plaza, Manchester M1 4BT, UK.
³ York Medical Group, York, UK.
⁴ Hull York Medical School, York University, York, UK.
⁵ School of Medicine, Keele University, Keele, UK.
⁶ Haywood Academic Rheumatology Centre, Midlands Partnership NHS Foundation Trust, Stoke-On-Trent, UK.

PMID: 36041743
DOI: 10.1136/bmj.o1754

No abstract available

MeSH terms

Gout Suppressants / therapeutic use
Gout* / diagnosis
Gout* / drug therapy
Humans

Substances

Gout Suppressants